Cumberland Pharmaceuticals (CPIX) Current Deferred Tax Assets (2010 - 2015)

Cumberland Pharmaceuticals has reported Current Deferred Tax Assets for 6 years, with the latest figure at $2.5 million in Q4 2015.

• Quarterly Current Deferred Tax Assets fell 30.74% year-over-year to $2.5 million in Q4 2015, while the trailing twelve-month figure through Dec 2015 was $2.5 million (down 30.74% YoY) and the FY2015 annual result came in at $2.5 million, down 30.74% from the prior year.
• Current Deferred Tax Assets retreated to $2.5 million in Q4 2015 per CPIX's latest filing, from $3.7 million in the prior quarter.
• Over five years, Current Deferred Tax Assets peaked at $3.7 million in Q4 2014 and troughed at $2.2 million in Q4 2011.
• A 5-year average of $2.7 million and a median of $2.5 million in 2015 frame the typical range for Current Deferred Tax Assets.
• The sharpest annual moves came in 2011 and 2015: Current Deferred Tax Assets surged 127.21% in 2011, then sank 30.74% in 2015.
• Over 5 years, Current Deferred Tax Assets stood at $2.2 million in 2011, then advanced by 2.98% to $2.3 million in 2012, then advanced by 18.4% to $2.7 million in 2013, then jumped by 34.65% to $3.7 million in 2014, then tumbled by 30.74% to $2.5 million in 2015.
• According to Business Quant data, Current Deferred Tax Assets over the past three periods registered $2.5 million, $3.7 million, and $2.7 million for Q4 2015, Q4 2014, and Q4 2013 respectively.